Yazdanbakhsh K. Review: complement receptor 1 therapeutics for prevention of immune hemolysis. Immunohematol 2005;21:109–18.10.21307/immunohematology-2019-402Search in Google Scholar
Davenport RD. Pathophysiology of hemolytic transfusion reactions. Semin Hematol 2005;42: 165–8.10.1053/j.seminhematol.2005.04.006Search in Google Scholar
Petz LD, Garratty G. Mechanisms of immune hemolysis. In: Petz LD, Garratty G, eds. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:133–65.Search in Google Scholar
Davenport RD. Cytokines as intercellular signals in hemolytic transfusion reactions. Biol Signals 1996; 5:240–5.10.1159/000109196Search in Google Scholar
Pineda AA, Brzica SM, Taswell HF. Hemolytic transfusion reaction: recent experience in a large blood bank. Mayo Clin Proc 1978;53:378–90.Search in Google Scholar
Schirmer DA, Song SC, Baliff JP, et al. Mouse models of IgG- and IgM-mediated hemolysis. Blood 2007; 109:3099–107.10.1182/blood-2006-08-040139Search in Google Scholar
Ness PM, Shirey RS, Weinstein MH, King KE. An animal model for delayed hemolytic transfusion reactions. Transfus Med Rev 2001;15:305–17.10.1053/tm.2001.26959Search in Google Scholar
Mollison PL. Survival curves of incompatible red cells. An analytical review. Transfusion 1986;26: 43–50.10.1046/j.1537-2995.1986.26186124030.xSearch in Google Scholar
Davenport RD, AABB Scientific Section Coordinating Committee. Guidelines for the laboratory evaluation of transfusion reactions. 2003. Bethesda, AABB (pamphlet).Search in Google Scholar
Standards for blood banks and transfusion services. 22nd ed. Bethesda: AABB, 2003:88–91.Search in Google Scholar
Petz LD, Garratty G. Hemolytic transfusion reactions. In: Petz LD, Garratty G, eds. Immune hemolytic anemias. 2nd ed. Philadelphia: Churchill Livingstone, 2004:541–72.Search in Google Scholar
Beauregard P, Blajchman MA. Hemolytic and pseudo-hemolytic transfusion reactions: an overview of the hemolytic transfusion reactions and the clinical conditions that mimic them. Transfus Med Rev 1994;8:184–99.10.1016/S0887-7963(94)70110-3Search in Google Scholar
Johnson ST, Fueger JT, Gottschall JL. One center’s experience: the serology and drugs associated with drug-induced immune hemolytic anemia—a new paradigm. Transfusion 2007;47:697–702.10.1111/j.1537-2995.2007.01173.x17381629Search in Google Scholar
Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005;293: 1653–62.10.1001/jama.293.13.165315811985Search in Google Scholar
Duvall CP, Alter HJ, Rath CE. Hemoglobin catabolism following a hemolytic transfusion reaction in a patient with sickle cell anemia. Transfusion 1974;14:382–7.10.1111/j.1537-2995.1974.tb04549.x4843246Search in Google Scholar
Capon SM, Goldfinger D. Acute hemolytic transfusion reaction, a paradigm of the systemic inflammatory response: new insights into pathophysiology and treatment. Transfusion 1995;35:513–20.10.1046/j.1537-2995.1995.35695288773.x7770905Search in Google Scholar
Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001; 29:1526–31.10.1097/00003246-200108000-0000511505120Search in Google Scholar
Uhl L, Kruskall MS. Complications of transfusion: transfusion reactions and transfusion-transmitted diseases. In: Young N, Gerson S, High K, eds. Clinical hematology. 1st ed. Philadelphia: Mosby, 2006:1272–89.Search in Google Scholar
Baumgarten R, van Gelder W, van Wintershoven J, Maaskant-Van Wijk PA, Beckers EA. Recurrent acute hemolytic transfusion reactions by antibodies against Doa antigens, not detected by crossmatching. Transfusion 2006;46:244–9.10.1111/j.1537-2995.2006.00707.x16441602Search in Google Scholar
Dzik WH. Emily Cooley Lecture 2002: transfusion safety in the hospital. Transfusion 2003;43: 1190–9.10.1046/j.1537-2995.2003.00523.x12919420Search in Google Scholar
Dodd RY, Notari EP, Stramer SL. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 2002;42:975–9.10.1046/j.1537-2995.2002.00174.x12385406Search in Google Scholar
Sazama K. Transfusion errors: scope of the problem, consequences, and solutions. Curr Hematol Rep 2003;2:518–21.Search in Google Scholar
Linden JV, Wagner K, Voytovich AE, Sheehan J. Transfusion errors in New York State: an analysis of 10 years’ experience. Transfusion 2000;40: 1207–13.10.1046/j.1537-2995.2000.40101207.x11061857Search in Google Scholar
Haemovigilance. Vox Sang 2006;90:207–41.10.1111/j.1423-0410.2006.00742.x16507025Search in Google Scholar
Brown T. Hemovigilance to biovigilance: an evolution of transfusion safety. Bethesda: AABB, 2007:19–25.Search in Google Scholar
